Developmental Processes in Schizophrenic Disorders: Cognitive Remediation, Medication Adherence, and Work Outcome in Recent-Onset Schizophrenia.
Phase of Trial: Phase IV
Latest Information Update: 24 Jun 2015
At a glance
- Drugs Risperidone (Primary)
- Indications Psychotic disorders; Schizoaffective disorder; Schizophrenia
- Focus Therapeutic Use
- 01 Jan 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 05 Oct 2011 Planned end date changed from 1 Mar 2011 to 1 Dec 2012 as reported by ClinicalTrials.gov.
- 16 Jun 2009 Ortho-McNeil-Janssen Pharmaceuticals added as trial sponsor and lead trial center as reported by ClinicalTrials.gov.